HomeREGULATORY
REGULATORY

MHLW Advisory Panel Backs Nexium’s Pediatric Dosages, Oral Suspension Form
(Nov.6.2017)

A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) on November 2 recommended approval for additional pediatric dosages and a new oral suspension formulation for AstraZeneca’s proton pump inhibitor (PPI) Nexium (esomeprazole) ...
(LOG IN FOR FULL STORY)

News Calendar